Prenetics Announces Third Quarter 2024 Financial Results
Prenetics Global Limited - Class A Ordinary Share (PRE)
Company Research
Source: GlobeNewswire
Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially Officially Launched IM8Health.com, a new premium supplements brand Tencent Invests $30 million in Insighta’s Early Cancer Detection Reiterates Revenue Target to Exceed $33 million for FY 2024 CHARLOTTE, N.C., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced unaudited financial results for the third quarter ended September 30, 2024, along with recent business updates. Third Quarter 2024 Financial Highlights Revenue from continuing operations of $7.8 million, as compared to $4.9 million in the third quarter 2023, an increase of 59.4%.Gross profit from continuing operations of $3.9 million, as compared to $1.7 million in the third quarter of 2023, an increase of 138.6%.Gross margin of continuing operations increased to 50.8% from 33.9% in the third quarter 2023, driven by operational effici
Show less
Read more
Impact Snapshot
Event Time:
PRE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRE alerts
High impacting Prenetics Global Limited - Class A Ordinary Share news events
Weekly update
A roundup of the hottest topics
PRE
News
- Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements [Yahoo! Finance]Yahoo! Finance
- Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium SupplementsPR Newswire
- Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium SupplementsGlobeNewswire
- Precision Nutrition Industry Assessment and Forecast to 2029: Revenues Anticipated to Reach $12.9 Billion - Case Study Analysis Featuring 23AndMe, Genesis Healthcare Co, and Viome Life Sciences [Yahoo! Finance]Yahoo! Finance
- iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024Accesswire
PRE
Sec Filings
- 12/13/24 - Form 6-K
- 11/27/24 - Form 6-K
- 11/14/24 - Form SC
- PRE's page on the SEC website